PlainRecalls
FDA Drug Moderate Class II Terminated

Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01

Reported: December 20, 2023 Initiated: November 22, 2023 #D-0148-2024

Product Description

Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01

Reason for Recall

Failed Dissolution Specifications

Details

Units Affected
N/A
Distribution
Product was distributed to 3 wholesale/distributor accounts.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: N/A.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on December 20, 2023. Severity: Moderate. Recall number: D-0148-2024.